
Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …

Johnson & Johnson is doubling down its efforts to grow its business in East Asia by identifying and recruiting promising …

The UK Government had already announced, as part of its industrial plan, that the life sciences were regarded as a …

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …

The September edition of Pharmafocus is now available – click here to read online.

Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …

New data on MSD’s anacetrapib has revealed that the drug was able to reduce risk of the risk of major …

AstraZeneca has announced plans to invest a multi-million sum into its £150 million facility in Macclesfield, Chesire, UK – a …

As much as it might try, the pharmaceutical industry just isn’t able to keep the drug pricing debate out of …

New data for AstraZeneca’s blood thinner Brilinta (ticagrelor) has shown that extended use of the drug can cut the risk …

Novartis has announced that it has appointed a new Chief Digital Officer in the form of Bertrand Bodson, who will …

Janssen has spoken out against plans to use an anaesthetic drug it invented over 50 years ago to execute prisoners, …